Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...

The contract biotech company plans to invest around $50 million to buy and renovate a Baltimore facility as it shifts more ...

What we want to do is remove about 0.35 acres of current site wetlands, in exchange for wetlands that are already in place, ...

Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor ...

Advancements in AI-driven flood forecasting are enabling faster, more efficient detection and response. For example, Google ...

Ireland hosts the world's ten largest drugmakers, including U.S. companies Johnson & Johnson, Pfizer, and Merck, all of which have large plants on the Emerald Isle. But for how long?

Gary Tiller, director or commercial operations with Vence, which is a U.S.-based company owned by Merck Animal Health, says ...

Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...